Detected ·
MAASH
€12.15M—
Brussels biotech MAASH secured a €12.15M funding package (€5.85M equity from Ambra Capital, InvestPro, Bpifrance, Bpifrance Amorçage Industriel, Nordzucker AG, and Tereos, plus €4.3M and a €2M loan from Bpifrance) to scale its LoCylia™ fermentation-derived mycoprotein for industrial production.
- Website
- www.maashcompany.com
- linkedin.com/company/maash
- Amount
- €12 150 000 EUR
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-26 22:32:13 UTC
- Signal ID
- 0b3454a3-ab67-4a9c-9b19-0658ed978a5b
As the API returns it
{
"id": "0b3454a3-ab67-4a9c-9b19-0658ed978a5b",
"created_at": "2026-08-26T22:32:13.022601Z",
"company_name": "MAASH",
"company_website_url": "www.maashcompany.com",
"company_linkedin_url": "https://www.linkedin.com/company/maash",
"event_type": "funding",
"funding_amount": 12150000,
"funding_currency": "EUR",
"funding_stage": null,
"message": "*Brussels biotech MAASH secured a €12.15M funding package (€5.85M equity from Ambra Capital, InvestPro, Bpifrance, Bpifrance Amorçage Industriel, Nordzucker AG, and Tereos, plus €4.3M and a €2M loan from Bpifrance) to scale its LoCylia™ fermentation-derived mycoprotein for industrial production.*"
}